BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 17692805)

  • 1. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
    Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
    Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.
    Demchenko YN; Glebov OK; Zingone A; Keats JJ; Bergsagel PL; Kuehl WM
    Blood; 2010 Apr; 115(17):3541-52. PubMed ID: 20053756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
    Annunziata CM; Davis RE; Demchenko Y; Bellamy W; Gabrea A; Zhan F; Lenz G; Hanamura I; Wright G; Xiao W; Dave S; Hurt EM; Tan B; Zhao H; Stephens O; Santra M; Williams DR; Dang L; Barlogie B; Shaughnessy JD; Kuehl WM; Staudt LM
    Cancer Cell; 2007 Aug; 12(2):115-30. PubMed ID: 17692804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
    J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
    Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R
    Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
    Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
    Bista P; Zeng W; Ryan S; Bailly V; Browning JL; Lukashev ME
    J Biol Chem; 2010 Apr; 285(17):12971-8. PubMed ID: 20185819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
    Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ
    Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
    Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
    Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
    Zarnegar BJ; Wang Y; Mahoney DJ; Dempsey PW; Cheung HH; He J; Shiba T; Yang X; Yeh WC; Mak TW; Korneluk RG; Cheng G
    Nat Immunol; 2008 Dec; 9(12):1371-8. PubMed ID: 18997794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signaling.
    Henry KL; Kellner D; Bajrami B; Anderson JE; Beyna M; Bhisetti G; Cameron T; Capacci AG; Bertolotti-Ciarlet A; Feng J; Gao B; Hopkins B; Jenkins T; Li K; May-Dracka T; Murugan P; Wei R; Zeng W; Allaire N; Buckler A; Loh C; Juhasz P; Lucas B; Ennis KA; Vollman E; Cahir-McFarland E; Hett EC; Ols ML
    Sci Signal; 2018 Jul; 11(541):. PubMed ID: 30065029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination.
    Jin X; Jin HR; Jung HS; Lee SJ; Lee JH; Lee JJ
    J Biol Chem; 2010 Oct; 285(40):30539-47. PubMed ID: 20682767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
    He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
    J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma.
    Rahal R; Frick M; Romero R; Korn JM; Kridel R; Chan FC; Meissner B; Bhang HE; Ruddy D; Kauffmann A; Farsidjani A; Derti A; Rakiec D; Naylor T; Pfister E; Kovats S; Kim S; Dietze K; Dörken B; Steidl C; Tzankov A; Hummel M; Monahan J; Morrissey MP; Fritsch C; Sellers WR; Cooke VG; Gascoyne RD; Lenz G; Stegmeier F
    Nat Med; 2014 Jan; 20(1):87-92. PubMed ID: 24362935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods to assess the activation of the alternative (noncanonical) NF-κB pathway by non-death TNF receptors.
    Remouchamps C; Dejardin E
    Methods Mol Biol; 2015; 1280():103-19. PubMed ID: 25736746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
    Zarnegar B; Yamazaki S; He JQ; Cheng G
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3503-8. PubMed ID: 18292232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs.
    Mukherjee T; Chatterjee B; Dhar A; Bais SS; Chawla M; Roy P; George A; Bal V; Rath S; Basak S
    EMBO J; 2017 Dec; 36(23):3501-3516. PubMed ID: 29061763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myeloma.
    Busino L; Millman SE; Pagano M
    Sci Signal; 2012 Dec; 5(253):pt14. PubMed ID: 23211527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
    Morrison MD; Reiley W; Zhang M; Sun SC
    J Biol Chem; 2005 Mar; 280(11):10018-24. PubMed ID: 15644327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XEDAR activates the non-canonical NF-κB pathway.
    Verhelst K; Gardam S; Borghi A; Kreike M; Carpentier I; Beyaert R
    Biochem Biophys Res Commun; 2015 Sep; 465(2):275-80. PubMed ID: 26260321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.